Abstract
SUMMARYSince 2018, the International Task Force on Benzodiazepines (ITFB), a group of academic psychiatrists and academic psychologists, has advocated that clinical guidelines should change to promote benzodiazepines from second- to first-line treatment for anxiety disorders, accept their use as maintenance treatment for anxiety conditions (in particular, panic disorder) and increase their use in gastrointestinal disorders. There is merit in much of what the ITFB argues, but in this article I analyse four major claims it has made in opinion editorials that I believe are not fully supported by the available evidence.
Publisher
Royal College of Psychiatrists
Subject
Psychiatry and Mental health
Reference46 articles.
1. Dependence potential of antidepressants compared to benzodiazepines
2. Antidepressants and benzodiazepines for panic disorder in adults;Bighelli;Cochrane Database of Systematic Reviews,2016
3. Sleep quality of benzodiazepine users in nursing homes: A comparative study with nonusers
4. Alliance for Benzodiazepine Best Practices (2022) About Us. Alliance for Benzodiazepine Best Practices (https://benzoreform.org/about-us). Accessed 18 Jun 2022.
5. ACG Clinical Guideline: Management of Irritable Bowel Syndrome
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献